POLO: A randomized phase III trial of olaparib maintenance monotherapy in patients (pts) with metastatic pancreatic cancer (mPC) who have a germline BRCA1/2 mutation (gBRCAm).

Affiliation auteurs!!!! Error affiliation !!!!
TitrePOLO: A randomized phase III trial of olaparib maintenance monotherapy in patients (pts) with metastatic pancreatic cancer (mPC) who have a germline BRCA1/2 mutation (gBRCAm).
Type de publicationJournal Article
Year of Publication2016
AuteursGolan T, Oh D-Y, Reni M, Macarulla TMercade, Tortora G, Hall MJ, Reinacher-Schick AC, Borg C, Hochhauser D, Walter T, Hochster HS, Baker N, Locker GY, Kindler HL
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.TPS4152